These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22118225)

  • 41. Guidelines to Compose an Ideal Bacteriophage Cocktail.
    Merabishvili M; Pirnay JP; De Vos D
    Methods Mol Biol; 2018; 1693():99-110. PubMed ID: 29119435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental Infection of Calves with Escherichia coli O104:H4 outbreak strain.
    Hamm K; Barth SA; Stalb S; Geue L; Liebler-Tenorio E; Teifke JP; Lange E; Tauscher K; Kotterba G; Bielaszewska M; Karch H; Menge C
    Sci Rep; 2016 Sep; 6():32812. PubMed ID: 27600997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental evolution for niche breadth in bacteriophage T4 highlights the importance of structural genes.
    Pham JY; Ogbunugafor CB; Nguyen Ba AN; Hartl DL
    Microbiologyopen; 2020 Feb; 9(2):e968. PubMed ID: 31778298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transmission of viruses via our microbiomes.
    Ly M; Jones MB; Abeles SR; Santiago-Rodriguez TM; Gao J; Chan IC; Ghose C; Pride DT
    Microbiome; 2016 Dec; 4(1):64. PubMed ID: 27912785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete genome sequence of a polyvalent bacteriophage, phiKP26, active on Salmonella and Escherichia coli.
    Amarillas L; Cháidez-Quiroz C; Sañudo-Barajas A; León-Félix J
    Arch Virol; 2013 Nov; 158(11):2395-8. PubMed ID: 23677676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of three different bacteriophage from mesophilic Aeromonas sp. that use different types of monopolar flagella as their primary receptor.
    Rubires X; Merino S; Aguilar A; Merceè Nogueras M; Tomaès JM
    FEMS Microbiol Lett; 1998 Apr; 161(1):53-7. PubMed ID: 24895749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A composite bacteriophage alters colonization by an intestinal commensal bacterium.
    Duerkop BA; Clements CV; Rollins D; Rodrigues JL; Hooper LV
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17621-6. PubMed ID: 23045666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of bacteriophages with a lytic effect on various Salmonella serotypes and Escherichia coli O157:H7.
    López-Cuevas O; Castro-Del Campo N; León-Félix J; González-Robles A; Chaidez C
    Can J Microbiol; 2011 Dec; 57(12):1042-51. PubMed ID: 22145760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus.
    Deng L; Roose K; Job ER; De Rycke R; Van Hamme E; Gonçalves A; Parthoens E; Cicchelero L; Sanders N; Fiers W; Saelens X
    J Control Release; 2017 Oct; 264():55-65. PubMed ID: 28842314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilization of T4 bacteriophage at acidic and basic pH by adsorption on paper.
    Meyer A; Greene M; Kimmelshue C; Cademartiri R
    Colloids Surf B Biointerfaces; 2017 Dec; 160():169-176. PubMed ID: 28926767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on veillonellophages isolated from washings of human oral cavity.
    Totsuka M
    Bull Tokyo Med Dent Univ; 1976 Dec; 23(4):261-73. PubMed ID: 1072190
    [No Abstract]   [Full Text] [Related]  

  • 53. Bacteroides fragilis and Escherichia coli bacteriophages in human faeces.
    Gantzer C; Henny J; Schwartzbrod L
    Int J Hyg Environ Health; 2002 May; 205(4):325-8. PubMed ID: 12068752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli.
    Carson L; Gorman SP; Gilmore BF
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):447-55. PubMed ID: 20528927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteriophage attack as an anti-biofilm strategy.
    Sillankorva S; Azeredo J
    Methods Mol Biol; 2014; 1147():277-85. PubMed ID: 24664841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacteriophage-resistant and bacteriophage-sensitive bacteria in a chemostat.
    Han Z; Smith HL
    Math Biosci Eng; 2012 Oct; 9(4):737-65. PubMed ID: 23311420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large-scale maps of variable infection efficiencies in aquatic Bacteroidetes phage-host model systems.
    Holmfeldt K; Solonenko N; Howard-Varona C; Moreno M; Malmstrom RR; Blow MJ; Sullivan MB
    Environ Microbiol; 2016 Nov; 18(11):3949-3961. PubMed ID: 27235779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pirates of the Caudovirales.
    Christie GE; Dokland T
    Virology; 2012 Dec; 434(2):210-21. PubMed ID: 23131350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacteriophage-based decontamination to control environmental colonization by
    Chavignon M; Kolenda C; Medina M; Bonhomme M; Blazere L; Legendre T; Tristan A; Laurent F; Butin M
    Front Cell Infect Microbiol; 2022; 12():1060825. PubMed ID: 36467721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Host range of chlamydiaphages phiCPAR39 and Chp3.
    Everson JS; Garner SA; Lambden PR; Fane BA; Clarke IN
    J Bacteriol; 2003 Nov; 185(21):6490-2. PubMed ID: 14563888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.